Healthcare provider profile · identity verified

Brian Dale Baker, MD

Family Practice · CHARLOTTE, NC · NPI 1891774626

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	312	89
Amlodipine Besylate	Amlodipine Besylate	290	86
Levothyroxine Sodium	Levothyroxine Sodium	225	64
Alprazolam	Alprazolam	198	29
Lisinopril	Lisinopril	180	48
Omeprazole	Omeprazole	171	53
Pantoprazole Sodium	Pantoprazole Sodium	171	50
Losartan Potassium	Losartan Potassium	132	41
Metformin Hcl Er	Metformin Hcl	123	35
Tamsulosin Hcl	Tamsulosin Hcl	120	40
Rosuvastatin Calcium	Rosuvastatin Calcium	118	39
Metformin Hcl	Metformin Hcl	112	29
Hydrochlorothiazide	Hydrochlorothiazide	106	31
Trazodone Hcl	Trazodone Hcl	95	33
Metoprolol Succinate	Metoprolol Succinate	92	29
Gabapentin	Gabapentin	87	30
Zolpidem Tartrate	Zolpidem Tartrate	87	17
Sertraline Hcl	Sertraline Hcl	85	23
Simvastatin	Simvastatin	79	24
Pravastatin Sodium	Pravastatin Sodium	72	22
Fluticasone Propionate	Fluticasone Propionate	69	27
Albuterol Sulfate Hfa	Albuterol Sulfate	65	21
Famotidine	Famotidine	62	24
Eliquis	Apixaban	60	17
Meloxicam	Meloxicam	60	16
Escitalopram Oxalate	Escitalopram Oxalate	59	18
Allopurinol	Allopurinol	58	14
Duloxetine Hcl	Duloxetine Hcl	57	16
Ozempic	Semaglutide	57	12
Potassium Chloride	Potassium Chloride	57	18
Bupropion Xl	Bupropion Hcl	54	16
Clonazepam	Clonazepam	54	13
Montelukast Sodium	Montelukast Sodium	52	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	14
Carvedilol	Carvedilol	49	15
Glimepiride	Glimepiride	49	12
Fluoxetine Hcl	Fluoxetine Hcl	48	11
Pioglitazone Hcl	Pioglitazone Hcl	47	11
Lorazepam	Lorazepam	43	11
Doxycycline Hyclate	Doxycycline Hyclate	42	35
Prednisone	Prednisone	41	29
Furosemide	Furosemide	40	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	39	11
Synthroid	Levothyroxine Sodium	39	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	35	11
Olmesartan Medoxomil	Olmesartan Medoxomil	34	11
Valacyclovir	Valacyclovir Hcl	34	14
Mounjaro	Tirzepatide	32	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	30	suppressed
Tramadol Hcl	Tramadol Hcl	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Finasteride	Finasteride	28	suppressed
Testosterone Cypionate	Testosterone Cypionate	28	suppressed
Baclofen	Baclofen	27	11
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Rybelsus	Semaglutide	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	23
Amoxicillin	Amoxicillin	26	23
Ezetimibe	Ezetimibe	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	suppressed
Ondansetron Odt	Ondansetron	23	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Fluconazole	Fluconazole	21	suppressed
Mupirocin	Mupirocin	21	14
Spironolactone	Spironolactone	21	suppressed
Ketoconazole	Ketoconazole	20	14
Meclizine Hcl	Meclizine Hcl	20	11
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Valsartan	Valsartan	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Myrbetriq	Mirabegron	18	suppressed
Telmisartan	Telmisartan	18	suppressed
Glipizide	Glipizide	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Ramipril	Ramipril	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Azithromycin	Azithromycin	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Estradiol	Estradiol	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Temazepam	Temazepam	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Atenolol	Atenolol	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Diazepam	Diazepam	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Metaxalone	Metaxalone	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Cefdinir	Cefdinir	11	11
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error